Sehavet Tezcan, Şerif Ercan, Özlem Çakır Madenci, Nihal Yücel, Asuman Orçun
Objective: In this study we aimed to calculate the reference intervals of carbohydrate antigen 15-3 (CA15-3), carbohydrate antigen 19-9 (CA19-9), carbohydrate antigen 125 (CA125) and carsinoembriyogenic antigen (CEA).
Materials and Methods: 325 healthy...
Journal of Turkish Clinical Biochemistry
•
2013-04-01
Fatma Ucar, Seyda Ozdemir, Gulfer Ozturk, Ali Yalcindag
Objectives: The carbohydrate antigen 19-9 assay is a widely used biomarker as a complement to other
tests in the detection and follow-up of pancreatic, bile duct and colon cancer in high-risk individuals.
The CA 19-9 assays often give different results with different...
Journal of Turkish Clinical Biochemistry
•
2022-08-01
•
DOI: 10.56615/tkbd.2022.10
Nergiz Zorbozan, Gökçe Filiz Atikeler, İlker Akarken
Aim: Laboratory results have an important effect on the clinical decision-making process. For this
reason, the analysis and reporting quality of the tests is extremely important. Measurement uncertainty
is the quantitative expression of the quality of test results. It is...
Journal of Turkish Clinical Biochemistry
•
2018-12-01
Serin Akbayır, Necati Muşlu
Search for other markers increase in prostate cancer diagnosis due to the lack of prostate-specific
antigen, but it has not yet found more sensitive and specific method to make diagnosis by exposing
patients less treatment. The exact diagnosis of prostate cancer continues to be made by...
Journal of Turkish Clinical Biochemistry
•
2016-12-01
Nilgün Tekkeşin
Ovarian cancer has often been described as a “silent killer,” but recent studies have shown that there
are symptoms that appear in the early stages of the disease. Recognition of these symptoms is critical
because early diagnosis improves the probability of cure. Use of serum biomarkers for the...
Journal of Turkish Clinical Biochemistry
•
2014-04-01
Niyazi Samet Yilmaz, Reyhan Ozturk, Bayram Sen, Mustafa Ulukanligil
Aim: Regarding coronavirus disease (COVID-19), despite antibody measurement alone providing insufficient data, studies evaluating immune responses to vaccination or disease have focused on humoral immunity. Uncoupled humoral and cellular responses may be present after...
Journal of Turkish Clinical Biochemistry
•
2023-12-01
•
DOI: 10.56615/tkbd.2023.20
Tevfik Noyan
D-dimer antigen is a fibrin degradation product that is formed by the sequential action of three different enzymes on cross-linked fibrin. As such, increased levels of plasma D-dimer should be reliable indicator of thrombus formation. The D-dimer antigen is a specific marker of fibrin clot...
Journal of Turkish Clinical Biochemistry
•
2012-04-01
Inanc Karakoyun, Fatma Demet Arslan
Aim: Pancreatic cancer (PC) is a disease with complex and poorly understood etiology. One of the
common risk factors of PC is diabetes mellitus (DM). Increased carbohydrate antigen (CA) 19-9 levels
can be used as a biomarker in diagnosis of PC. However, CA 19-9 levels have...
Journal of Turkish Clinical Biochemistry
•
2020-12-01
Nergiz Zorbozan, İlker Akarken
Objective: The aim of study was to determine unnecessary repeated total prostate specific
antigen(tPSA) according to minimum retest interval and to evaluate the change between consecutive
measurement results with RCV.
Material and Methods: According...
Journal of Turkish Clinical Biochemistry
•
2019-04-01
A. Erkin Bozdemir, Burcu Barutçuoğlu, Fatih Ekren, Ceyda Kabaroğlu, Gürhan Günaydın, Sara Habif, Çağ Çal, Oya Bayındır
Objective: Prostate specific antigen (PSA) and ma ny other tumor markers are suggested to be useful for the biologic activity of the prostate cancer. The aim of our study is to investigate possible relationship between inflammatory markers (high sensitive C-Reactive Protein...
Journal of Turkish Clinical Biochemistry
•
2006-12-01